GO ZOLV Trademark

Trademark Overview

On Thursday, May 28, 2015, a trademark application was filed for GO ZOLV with the United States Patent and Trademark Office. The USPTO has given the GO ZOLV trademark a serial number of 79170027. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 30, 2022. This trademark is owned by Dexcel Pharma Technologies Ltd.. The GO ZOLV trademark is filed in the Pharmaceutical Products category with the following description:

Orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders
go zolv

General Information

Serial Number79170027
Word MarkGO ZOLV
Filing DateThursday, May 28, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 30, 2022
Registration Number4916071
Registration DateTuesday, March 15, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2015

Trademark Statements

Goods and ServicesOrally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, cardiovascular, central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, dermatological, infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, erectile dysfunction, sexual dysfunction, gynecology, obstetric, pediatric, hematologic, oncological, fungal and viral diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDexcel Pharma Technologies Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL
Party NameDexcel Pharma Technologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL
Party NameDexcel Pharma Technologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, June 28, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, June 28, 2023INVALIDATION PROCESSED
Tuesday, May 30, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 30, 2022CANCELLED SECTION 71
Monday, March 15, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, August 23, 2017LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, July 7, 2017LIMITATION OF GOODS RECEIVED FROM IB
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 20, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 20, 2016FINAL DISPOSITION PROCESSED
Wednesday, June 15, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 15, 2016REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 29, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 9, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 12, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 2, 2015REFUSAL PROCESSED BY IB
Monday, September 14, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 14, 2015REFUSAL PROCESSED BY MPU
Saturday, September 12, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 11, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 9, 2015ASSIGNED TO EXAMINER
Tuesday, August 11, 2015APPLICATION FILING RECEIPT MAILED
Friday, August 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 6, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zolv dysfunction orally disintegrating respiratory urogenital urological psychiatric neurological musculoskeletal connective